Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Pacira BioSciences
PCRX
$1.03B
| $9.92M | ﹤0.01% |
257,009
-52,227
| -17% | -$2.54M |
|
1702
Morningstar
MORN
$7.47B
| $9.91M | ﹤0.01% |
45,745
+100
| +0.2% | +$22.8K |
|
|
SRC
1703
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $9.9M | ﹤0.01% |
247,231
-19,747
| -7% | -$771K |
|
1704
First Financial Bancorp
FFBC
$3.59B
| $9.87M | ﹤0.01% |
407,422
-59,831
| -13% | -$1.47M |
|
|
KKR.PRC
1705
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
| $9.85M | ﹤0.01% |
171,695
+8,942
| +5% | +$539K |
|
1706
Lantheus
LNTH
$6.61B
| $9.84M | ﹤0.01% |
193,103
-152,238
| -44% | -$9.39M |
|
1707
MillerKnoll
MLKN
$1.63B
| $9.82M | ﹤0.01% |
467,597
+193,470
| +71% | +$3.87M |
|
1708
Spire
SR
$4.73B
| $9.82M | ﹤0.01% |
142,510
-362
| -0.3% | -$24.6K |
|
1709
Toast
TOST
$19.1B
| $9.81M | ﹤0.01% |
544,141
-149,936
| -22% | -$2.82M |
|
1710
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.07B
| $9.77M | ﹤0.01% |
105,120
-120,898
| -53% | -$11.5M |
|
1711
Crane NXT
CXT
$3.05B
| $9.75M | ﹤0.01% |
279,519
-23,421
| -8% | -$817K |
|
|
LHCG
1712
DELISTED
LHC Group LLC
LHCG
| $9.72M | ﹤0.01% |
60,144
-5,003
| -8% | -$826K |
|
1713
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$598M
| $9.71M | ﹤0.01% |
250,646
-109,117
| -30% | -$4.28M |
|
1714
Credicorp
BAP
$31.6B
| $9.69M | ﹤0.01% |
71,458
+7,362
| +11% | +$1.04M |
|
1715
Tandem Diabetes Care
TNDM
$1.39B
| $9.69M | ﹤0.01% |
215,908
-2,686
| -1% | -$122K |
|
1716
Avantor
AVTR
$9.2B
| $9.69M | ﹤0.01% |
459,205
+36,520
| +9% | +$756K |
|
1717
Whirlpool
WHR
$2.56B
| $9.66M | ﹤0.01% |
68,367
-3,252
| -5% | -$462K |
|
1718
Sterling Infrastructure
STRL
$18.7B
| $9.65M | ﹤0.01% |
294,157
-24,164
| -8% | -$711K |
|
1719
FNB Corp
FNB
$6.82B
| $9.64M | ﹤0.01% |
738,493
-55,924
| -7% | -$749K |
|
1720
Dine Brands
DIN
$458M
| $9.61M | ﹤0.01% |
148,656
-2,060
| -1% | -$143K |
|
1721
iShares Morningstar Mid-Cap ETF
IMCB
$1.67B
| $9.6M | ﹤0.01% |
163,405
-869
| -0.5% | -$50.8K |
|
1722
Southern First Bancshares
SFST
$597M
| $9.58M | ﹤0.01% |
209,443
+4,177
| +2% | +$190K |
|
1723
EnerSys
ENS
$6.84B
| $9.57M | ﹤0.01% |
129,572
-6,077
| -4% | -$424K |
|
1724
Interactive Brokers
IBKR
$38.9B
| $9.56M | ﹤0.01% |
528,664
-12,052
| -2% | -$225K |
|
1725
Kforce
KFRC
$1.04B
| $9.56M | ﹤0.01% |
174,290
-88,275
| -34% | -$5.1M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.